The role of lymphocytes in radiotherapy-induced adverse late effects in the lung

Frontiers in Immunology

Volumn 7, Issue DEC, 2016, Pages

  Wirsdörfer, Florian ^a   Jendrossek, Verena ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Fibrosis; Lung; Lymphocytes; Pneumonitis; Radiotherapy

Indexed keywords

ALPHA TOCOPHEROL; CHEMOKINE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; LISOFYLLINE; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CANCER GROWTH; CANCER RADIOTHERAPY; CD4+ T LYMPHOCYTE; DEFENSE MECHANISM; ENDOTHELIUM CELL; FIBROBLAST CULTURE; FIBROSIS; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IONIZING RADIATION; LUNG DISEASE; LUNG INJURY; MESENCHYMAL STEM CELL; NATURAL KILLER CELL; NONHUMAN; PNEUMONIA; RADIATION; RADIATION PNEUMONIA; REVIEW; STROMA CELL; T LYMPHOCYTE;

EID: 85009388531     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00591     Document Type: Review

References (266)

1. Bartelink H, Rubens RD, van der Schueren E, Sylvester R. Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European organization for research and treatment of cancer randomized phase III trial. J Clin Oncol (1997) 15(1):207-15.
2. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol (1997) 15(5):2040-9.
3. Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol (2011) 100(1):33-40. doi:10.1016/j.radonc.2011.05.036
4. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med (2006) 355(11):1114-23. doi:10.1056/NEJMoa060829
5. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet (2001) 358(9284):781-6. doi:10.1016/S0140-6736(01)05965-7
6. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med (1992) 326(24):1593-8. doi:10.1056/NEJM199206113262403
7. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 352(10):987-96. doi:10.1056/NEJMoa043330
8. Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol (2010) 28(13):2181-90. doi:10.1200/JCO.2009.26.2543
9. Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer (2008) 8(7):545-54. doi:10.1038/nrc2419
10. Yu VY, Nguyen D, Pajonk F, Kupelian P, Kaprealian T, Selch M, et al. Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance. Int J Radiat Oncol Biol Phys (2015) 91(4):866-75. doi:10.1016/j.ijrobp.2014.12.004
11. Leder K, Pitter K, Laplant Q, Hambardzumyan D, Ross BD, Chan TA, et al. Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules. Cell (2014) 156(3):603-16. doi:10.1016/j.cell.2013.12.029
12. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 366(10):883-92. doi:10.1056/NEJMoa1113205
13. Holzel M, Bovier A, Tuting T. Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance? Nat Rev Cancer (2013) 13(5):365-76. doi:10.1038/nrc3498
14. Kim JJ, Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer (2005) 5(7):516-25. doi:10.1038/nrc1650
15. Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer (2011) 11(4):239-53. doi:10.1038/nrc3007
16. Herman JM, Narang AK, Griffith KA, Zalupski MM, Reese JB, Gearhart SL, et al. The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2013) 85(1):e15-9. doi:10.1016/j.ijrobp.2012.09.006
17. Budach W, Hehr T, Budach V, Belka C, Dietz K. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer (2006) 6:28. doi:10.1186/1471-2407-6-28
18. Morgan MA, Parsels LA, Maybaum J, Lawrence TS. Improving the efficacy of chemoradiation with targeted agents. Cancer Discov (2014) 4(3):280-91. doi:10.1158/2159-8290.CD-13-0337
19. Tsoutsou PG, Koukourakis MI. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys (2006) 66(5):1281-93. doi:10.1016/j.ijrobp.2006.08.058
20. Kong FM, Ten Haken R, Eisbruch A, Lawrence TS. Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis. Semin Oncol (2005) 32(2 Suppl 3):S42-54. doi:10.1053/j.seminoncol.2005.03.009
21. Kelsey CR, Horwitz ME, Chino JP, Craciunescu O, Steffey B, Folz RJ, et al. Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors. Int J Radiat Oncol Biol Phys (2011) 81(3):812-8. doi:10.1016/j.ijrobp.2010.06.058
22. McDonald S, Rubin P, Phillips TL, Marks LB. Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys (1995) 31(5):1187-203. doi:10.1016/0360-3016(94)00429-O
23. Provatopoulou X, Athanasiou E, Gounaris A. Predictive markers of radiation pneumonitis. Anticancer Res (2008) 28(4C):2421-32.
24. Graves PR, Siddiqui F, Anscher MS, Movsas B. Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol (2010) 20(3):201-7. doi:10.1016/j.semradonc.2010.01.010
25. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med (2012) 18(7):1028-40. doi:10.1038/nm.2807
26. Abdollahi A, Li M, Ping G, Plathow C, Domhan S, Kiessling F, et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med (2005) 201(6):925-35. doi:10.1084/jem.20041393
27. Arpin D, Perol D, Blay JY, Falchero L, Claude L, Vuillermoz-Blas S, et al. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol (2005) 23(34):8748-56. doi:10.1200/JCO.2005.01.7145
28. Kasper M, Haroske G. Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis. Histol Histopathol (1996) 11(2):463-83.
29. Penney DP, Siemann DW, Rubin P, Maltby K. Morphological correlates of fractionated radiation of the mouse lung: early and late effects. Int J Radiat Oncol Biol Phys (1994) 29(4):789-804. doi:10.1016/0360-3016(94)90568-1
30. Roberts CM, Foulcher E, Zaunders JJ, Bryant DH, Freund J, Cairns D, et al. Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med (1993) 118(9):696-700. doi:10.7326/0003-4819-118-9-199305010-00006
31. Rübe CE, Uthe D, Wilfert F, Ludwig D, Yang K, Konig J, et al. The bronchiolar epithelium as a prominent source of pro-inflammatory cytokines after lung irradiation. Int J Radiat Oncol Biol Phys (2005) 61(5):1482-92. doi:10.1016/j.ijrobp.2004.12.072
32. Trott KR, Herrmann T, Kasper M. Target cells in radiation pneumopathy. Int J Radiat Oncol Biol Phys (2004) 58(2):463-9. doi:10.1016/j.ijrobp.2003.09.045
33. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys (1995) 33(1):99-109. doi:10.1016/0360-3016(95)00095-G
34. McBride WH, Chiang CS, Olson JL, Wang CC, Hong JH, Pajonk F, et al. A sense of danger from radiation. Radiat Res (2004) 162(1):1-19. doi:10.1667/RR3196
35. Wirsdörfer F, de Leve S, Cappuccini F, Eldh T, Meyer AV, Gau E, et al. Extracellular adenosine production by ecto-5'-nucleotidase (CD73) enhances radiation-induced lung fibrosis. Cancer Res (2016) 76(10):3045-56. doi:10.1158/0008-5472.CAN-15-2310
36. Klein D, Schmetter A, Imsak R, Wirsdorfer F, Unger K, Jastrow H, et al. Therapy with multipotent mesenchymal stromal cells protects lungs from radiation-induced injury and reduces the risk of lung metastasis. Antioxid Redox Signal (2016) 24(2):53-69. doi:10.1089/ars.2014.6183
37. Klein D, Steens J, Wiesemann A, Schulz F, Kaschani F, Rock K, et al. Mesenchymal stem cell therapy protects lungs from radiation-induced endothelial cell loss by restoring superoxide dismutase 1 expression. Antioxid Redox Signal (2016). doi:10.1089/ars.2016.6748
38. Johnston CJ, Williams JP, Elder A, Hernady E, Finkelstein JN. Inflammatory cell recruitment following thoracic irradiation. Exp Lung Res (2004) 30(5):369-82. doi:10.1080/01902140490438915
39. Martin C, Romero S, Sanchez-Paya J, Massuti B, Arriero JM, Hernandez L. Bilateral lymphocytic alveolitis: a common reaction after unilateral thoracic irradiation. Eur Respir J (1999) 13(4):727-32. doi:10.1034/j.1399-3003.1999.13d05.x
40. Toma CL, Serbescu A, Alexe M, Cervis L, Ionita D, Bogdan MA. The bronchoalveolar lavage pattern in radiation pneumonitis secondary to radiotherapy for breast cancer. Maedica (Buchar) (2010) 5(4):250-7.
41. Morgan GW, Breit SN. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys (1995) 31(2):361-9. doi:10.1016/0360-3016(94)00477-3
42. Nakayama Y, Makino S, Fukuda Y, Min KY, Shimizu A, Ohsawa N. Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys (1996) 34(2):459-67. doi:10.1016/0360-3016(95)02101-9
43. Westermann W, Schobl R, Rieber EP, Frank KH. Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat. Int J Radiat Biol (1999) 75(5):629-38. doi:10.1080/095530099140276
44. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med (1989) 170(3):655-63. doi:10.1084/jem.170.3.655
45. Sharma SK, MacLean JA, Pinto C, Kradin RL. The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury. Am J Respir Crit Care Med (1996) 154(1):193-200. doi:10.1164/ajrccm.154.1.8680680
46. Cappuccini F, Eldh T, Bruder D, Gereke M, Jastrow H, Schulze-Osthoff K, et al. New insights into the molecular pathology of radiation-induced pneumopathy. Radiother Oncol (2011) 101(1):86-92. doi:10.1016/j.radonc.2011.05.064
47. Todd NW, Luzina IG, Atamas SP. Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair (2012) 5(1):11. doi:10.1186/1755-1536-5-11
48. Youngblood B, Davis CW, Ahmed R. Making memories that last a lifetime: heritable functions of self-renewing memory CD8 T cells. Int Immunol (2010) 22(10):797-803. doi:10.1093/intimm/dxq437
49. Born WK, Jin N, Aydintug MK, Wands JM, French JD, Roark CL, et al. Gammadelta T lymphocytes-selectable cells within the innate system? J Clin Immunol (2007) 27(2):133-44. doi:10.1007/s10875-007-9077-z
50. Larosa DF, Orange JS. 1. Lymphocytes. J Allergy Clin Immunol (2008) 121(2 Suppl):S364-9. doi:10.1016/j.jaci.2007.06.016
51. Holtmeier W, Kabelitz D. Gammadelta T cells link innate and adaptive immune responses. Chem Immunol Allergy (2005) 86:151-83. doi:10.1159/000086659
52. Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ. Helper T cell diversity and plasticity. Curr Opin Immunol (2012) 24(3):297-302. doi:10.1016/j.coi.2012.01.014
53. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol (2005) 6(11):1123-32. doi:10.1038/ni1254
54. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 299(5609):1057-61. doi:10.1126/science.1079490
55. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol (2004) 4(3):231-7. doi:10.1038/nri1309
56. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med (2000) 192(11):1553-62. doi:10.1084/jem.192.11.1553
57. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest (2009) 119(12):3573-85. doi:10.1172/JCI40202
58. Stassen M, Schmitt E, Bopp T. From interleukin-9 to T helper 9 cells. Ann N Y Acad Sci (2012) 1247:56-68. doi:10.1111/j.1749-6632.2011.06351.x
59. Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis (1999) 5(4):285-94. doi:10.1002/ibd.3780050410
60. Homey B. [After TH1/TH2 now comes Treg/TH17: significance of T helper cells in immune response organization]. Hautarzt (2006) 57(8):730-2. doi:10.1007/s00105-006-1199-3
61. Chen Z, O'Shea JJ. Regulation of IL-17 production in human lymphocytes. Cytokine (2008) 41(2):71-8. doi:10.1016/j.cyto.2007.09.009
62. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity (2006) 24(6):677-88. doi:10.1016/j.immuni.2006.06.002
63. Noma T. [Helper T cell paradigm: Th17 and regulatory T cells involved in autoimmune inflammatory disorders, pathogen defense and allergic diseases]. Nihon Rinsho Men'eki Gakkai kaishi (2010) 33(5):262-71. doi:10.2177/jsci.33.262
64. Hartigan-O'Connor DJ, Poon C, Sinclair E, McCune JM. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods (2007) 319(1-2):41-52. doi:10.1016/j.jim.2006.10.008
65. Churlaud G, Pitoiset F, Jebbawi F, Lorenzon R, Bellier B, Rosenzwajg M, et al. Human and mouse CD8(+)CD25(+)FOXP3(+) regulatory T cells at steady state and during interleukin-2 therapy. Front Immunol (2015) 6:171. doi:10.3389/fimmu.2015.00171
66. Drolet JP, Frangie H, Guay J, Hajoui O, Hamid Q, Mazer BD. B lymphocytes in inflammatory airway diseases. Clin Exp Allergy (2010) 40(6):841-9. doi:10.1111/j.1365-2222.2010.03512.x
67. Tussiwand R, Bosco N, Ceredig R, Rolink AG. Tolerance checkpoints in B-cell development: Johnny B good. Eur J Immunol (2009) 39(9):2317-24. doi:10.1002/eji.200939633
68. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol (2012) 30:221-41. doi:10.1146/annurev-immunol-020711-074934
69. Shimabukuro-Vornhagen A, Draube A, Liebig T, Popov A, Rothe A, von Bergwelt-Baildon M. The properties of human CD40-activated B cells as antigen-presenting cells are not affected by PGE2. Oncol Rep (2013) 29(3):1061-5. doi:10.3892/or.2012.2215
70. Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells-how did we miss them? Nat Rev Immunol (2013) 13(2):75-87. doi:10.1038/nri3349
71. Gasteiger G, Rudensky AY. Interactions between innate and adaptive lymphocytes. Nat Rev Immunol (2014) 14(9):631-9. doi:10.1038/nri3726
72. Eberl G, Colonna M, Di Santo JP, McKenzie AN. Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology. Science (2015) 348(6237):aaa6566. doi:10.1126/science.aaa6566
73. Ishizuka IE, Constantinides MG, Gudjonson H, Bendelac A. The innate lymphoid cell precursor. Annu Rev Immunol (2016) 34:299-316. doi:10.1146/annurev-immunol-041015-055549
74. Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol (2008) 8(2):142-52. doi:10.1038/nri2236
75. Hamada H, Bassity E, Flies A, Strutt TM, Garcia-Hernandez Mde L, McKinstry KK, et al. Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection. J Immunol (2013) 190(1):296-306. doi:10.4049/jimmunol.1200571
76. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med (2007) 13(2):139-45. doi:10.1038/nm1551
77. Duan MC, Han W, Jin PW, Wei YP, Wei Q, Zhang LM, et al. Disturbed Th17/treg balance in patients with non-small cell lung cancer. Inflammation (2015) 38(6):2156-65. doi:10.1007/s10753-015-0198-x
78. Umetsu DT, DeKruyff RH. The regulation of allergy and asthma. Immunol Rev (2006) 212:238-55. doi:10.1111/j.0105-2896.2006.00413.x
79. Liu F, Liu J, Weng D, Chen Y, Song L, He Q, et al. CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice. PLoS One (2010) 5(11):e15404. doi:10.1371/journal.pone.0015404
80. Xiong S, Guo R, Yang Z, Xu L, Du L, Li R, et al. Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-gamma, IL-12/IL-4, IL-5 balance. Immunobiology (2015) 220(11):1284-91. doi:10.1016/j.imbio.2015.07.001
81. Xiong S, Pan X, Xu L, Yang Z, Guo R, Gu Y, et al. Regulatory T cells promote beta-catenin-mediated epithelium-to-mesenchyme transition during radiation-induced pulmonary fibrosis. Int J Radiat Oncol Biol Phys (2015) 93(2):425-35. doi:10.1016/j.ijrobp.2015.05.043
82. Wands JM, Roark CL, Aydintug MK, Jin N, Hahn YS, Cook L, et al. Distribution and leukocyte contacts of gammadelta T cells in the lung. J Leukoc Biol (2005) 78(5):1086-96. doi:10.1189/jlb.0505244
83. Nanno M, Shiohara T, Yamamoto H, Kawakami K, Ishikawa H. Gammadelta T cells: firefighters or fire boosters in the front lines of inflammatory responses. Immunol Rev (2007) 215:103-13. doi:10.1111/j.1600-065X.2006.00474.x
84. Simonian PL, Wehrmann F, Roark CL, Born WK, O'Brien RL, Fontenot AP. Gammadelta T cells protect against lung fibrosis via IL-22. J Exp Med (2010) 207(10):2239-53. doi:10.1084/jem.20100061
85. Boyden AW, Legge KL, Waldschmidt TJ. Pulmonary infection with influenza A virus induces site-specific germinal center and T follicular helper cell responses. PLoS One (2012) 7(7):e40733. doi:10.1371/journal.pone.0040733
86. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med (2008) 14(3):275-81. doi:10.1038/nm1710
87. Ying X, Su Z, Bie Q, Zhang P, Yang H, Wu Y, et al. Synergistically increased ILC2 and Th9 cells in lung tissue jointly promote the pathological process of asthma in mice. Mol Med Rep (2016) 13(6):5230-40. doi:10.3892/mmr.2016.5174
88. Lund FE, Hollifield M, Schuer K, Lines JL, Randall TD, Garvy BA. B cells are required for generation of protective effector and memory CD4 cells in response to pneumocystis lung infection. J Immunol (2006) 176(10):6147-54. doi:10.4049/jimmunol.176.10.6147
89. Onodera T, Takahashi Y, Yokoi Y, Ato M, Kodama Y, Hachimura S, et al. Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection. Proc Natl Acad Sci U S A (2012) 109(7):2485-90. doi:10.1073/pnas.1115369109
90. Monticelli LA, Sonnenberg GF, Artis D. Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung. Curr Opin Immunol (2012) 24(3):284-9. doi:10.1016/j.coi.2012.03.012
91. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol (2011) 12(11):1045-54. doi:10.1031/ni.2131
92. Kim HY, Chang YJ, Subramanian S, Lee HH, Albacker LA, Matangkasombut P, et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol (2012) 129(1):e1-6. doi:10.1016/j.jaci.2011.10.036
93. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol (2011) 12(7):631-8. doi:10.1038/ni.2045
94. Marashian SM, Mortaz E, Jamaati HR, Alavi-Moghaddam M, Kiani A, Abedini A, et al. Role of innate lymphoid cells in lung disease. Iran J Allergy Asthma Immunol (2015) 14(4):346-60.
95. Lai DM, Shu Q, Fan J. The origin and role of innate lymphoid cells in the lung. Mil Med Res (2016) 3:25. doi:10.1186/s40779-016-0093-2
96. Gasteiger G, Fan X, Dikiy S, Lee SY, Rudensky AY. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science (2015) 350(6263):981-5. doi:10.1126/science.aac9593
97. Li BW, Hendriks RW. Group 2 innate lymphoid cells in lung inflammation. Immunology (2013) 140(3):281-7. doi:10.1111/imm.12153
98. De Grove KC, Provoost S, Verhamme FM, Bracke KR, Joos GF, Maes T, et al. Characterization and quantification of innate lymphoid cell subsets in human lung. PLoS One (2016) 11(1):e0145961. doi:10.1371/journal.pone.0145961
99. Muir R, Osbourn M, Dubois AV, Doran E, Small DM, Monahan A, et al. Innate lymphoid cells are the predominant source of IL-17A during the early pathogenesis of acute respiratory distress syndrome. Am J Respir Crit Care Med (2016) 193(4):407-16. doi:10.1164/rccm.201410-1782OC
100. Roediger B, Kyle R, Tay SS, Mitchell AJ, Bolton HA, Guy TV, et al. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation. J Allergy Clin Immunol (2015) 136(6):1653-63.e1-7. doi:10.1016/j.jaci.2015.03.043
101. Denney L, Byrne AJ, Shea TJ, Buckley JS, Pease JE, Herledan GM, et al. Pulmonary epithelial cell-derived cytokine TGF-beta1 is a critical cofactor for enhanced innate lymphoid cell function. Immunity (2015) 43(5):945-58. doi:10.1016/j.immuni.2015.10.012
102. Zhang Y, Tang J, Tian Z, van Velkinburgh JC, Song J, Wu Y, et al. Innate lymphoid cells: a promising new regulator in fibrotic diseases. Int Rev Immunol (2015) 19:1-16. doi:10.3109/08830185.2015.1068304
103. Luzina IG, Kopach P, Lockatell V, Kang PH, Nagarsekar A, Burke AP, et al. Interleukin-33 potentiates bleomycin-induced lung injury. Am J Respir Cell Mol Biol (2013) 49(6):999-1008. doi:10.1165/rcmb.2013-0093OC
104. Li D, Guabiraba R, Besnard AG, Komai-Koma M, Jabir MS, Zhang L, et al. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J Allergy Clin Immunol (2014) 134(6):1422.e-32.e. doi:10.1016/j.jaci.2014.05.011
105. Hams E, Armstrong ME, Barlow JL, Saunders SP, Schwartz C, Cooke G, et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci U S A (2014) 111(1):367-72. doi:10.1073/pnas.1315854111
106. Hams E, Bermingham R, Fallon PG. Macrophage and innate lymphoid cell interplay in the genesis of fibrosis. Front Immunol (2015) 6:597. doi:10.3389/fimmu.2015.00597
107. Goodhead DT. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol (1994) 65(1):7-17. doi:10.1080/09553009414550021
108. Riley PA. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol (1994) 65(1):27-33. doi:10.1080/09553009414550041
109. Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol (2002) 30(6):513-28. doi:10.1016/S0301-472X(02)00802-0
110. Belka C, Ottinger H, Kreuzfelder E, Weinmann M, Lindemann M, Lepple-Wienhues A, et al. Impact of localized radiotherapy on blood immune cells counts and function in humans. Radiother Oncol (1999) 50(2):199-204. doi:10.1016/S0167-8140(98)00130-3
111. Yao Z, Jones J, Kohrt H, Strober S. Selective resistance of CD44hi T cells to p53-dependent cell death results in persistence of immunologic memory after total body irradiation. J Immunol (2011) 187(8):4100-8. doi:10.4049/jimmunol.1101141
112. Kachikwu EL, Iwamoto KS, Liao YP, DeMarco JJ, Agazaryan N, Economou JS, et al. Radiation enhances regulatory T cell representation. Int J Radiat Oncol Biol Phys (2011) 81(4):1128-35. doi:10.1016/j.ijrobp.2010.09.034
113. Qu Y, Jin S, Zhang A, Zhang B, Shi X, Wang J, et al. Gamma-ray resistance of regulatory CD4+CD25+Foxp3+ T cells in mice. Radiat Res (2010) 173(2):148-57. doi:10.1667/RR0978.1
114. Bogdandi EN, Balogh A, Felgyinszki N, Szatmari T, Persa E, Hildebrandt G, et al. Effects of low-dose radiation on the immune system of mice after total-body irradiation. Radiat Res (2010) 174(4):480-9. doi:10.1667/RR2160.1
115. DeKruyff RH, Fang Y, Umetsu DT. IL-4-based helper activity of CD4+ T cells is radiation sensitive. Cell Immunol (1995) 160(2):248-56. doi:10.1016/0008-8749(95)80035-H
116. Chua ML, Rothkamm K. Biomarkers of radiation exposure: can they predict normal tissue radiosensitivity? Clin Oncol (R Coll Radiol) (2013) 25(10):610-6. doi:10.1016/j.clon.2013.06.010
117. Vandevoorde C, Depuydt J, Veldeman L, De Neve W, Sebastia N, Wieme G, et al. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study. Int J Radiat Biol (2016) 92(12):823-36. doi:10.1080/09553002.2016.1230238
118. Geara FB, Peters LJ, Ang KK, Wike JL, Brock WA. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys (1993) 27(5):1173-9. doi:10.1016/0360-3016(93)90540-C
119. Ozsahin M, Crompton NE, Gourgou S, Kramar A, Li L, Shi Y, et al. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res (2005) 11(20):7426-33. doi:10.1158/1078-0432.CCR-04-2634
120. Mori M, Benotmane MA, Tirone I, Hooghe-Peters EL, Desaintes C. Transcriptional response to ionizing radiation in lymphocyte subsets. Cell Mol Life Sci (2005) 62(13):1489-501. doi:10.1007/s00018-005-5086-3
121. Gruel G, Voisin P, Vaurijoux A, Roch-Lefevre S, Gregoire E, Maltere P, et al. Broad modulation of gene expression in CD4+ lymphocyte subpopulations in response to low doses of ionizing radiation. Radiat Res (2008) 170(3):335-44. doi:10.1667/RR1147.1
122. Gridley DS, Rizvi A, Luo-Owen X, Makinde AY, Pecaut MJ. Low dose, low dose rate photon radiation modifies leukocyte distribution and gene expression in CD4(+) T cells. J Radiat Res (2009) 50(2):139-50. doi:10.1269/jrr.08095
123. Vatner RE, Cooper BT, Vanpouille-Box C, Demaria S, Formenti SC. Combinations of immunotherapy and radiation in cancer therapy. Front Oncol (2014) 4:325. doi:10.3389/fonc.2014.00325
124. Balermpas P, Michel Y, Wagenblast J, Seitz O, Weiss C, Rodel F, et al. Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. Br J Cancer (2014) 110(2):501-9. doi:10.1038/bjc.2013.640
125. Schaue D, McBride WH. T lymphocytes and normal tissue responses to radiation. Front Oncol (2012) 2:119. doi:10.3389/fonc.2012.00119
126. Travis EL, Vojnovic B, Davies EE, Hirst DG. A plethysmographic method for measuring function in locally irradiated mouse lung. Br J Radiol (1979) 52(613):67-74. doi:10.1259/0007-1285-52-613-67
127. Eldh T, Heinzelmann F, Velalakan A, Budach W, Belka C, Jendrossek V. Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time-and dose-dependent. Strahlenther Onkol (2012) 188(3):274-81. doi:10.1007/s00066-011-0046-3
128. Chiang CS, Liu WC, Jung SM, Chen FH, Wu CR, McBride WH, et al. Compartmental responses after thoracic irradiation of mice: strain differences. Int J Radiat Oncol Biol Phys (2005) 62(3):862-71. doi:10.1016/j.ijrobp.2005.02.037
129. Flechsig P, Dadrich M, Bickelhaupt S, Jenne J, Hauser K, Timke C, et al. LY2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-beta and BMP-associated proinflammatory and proangiogenic signals. Clin Cancer Res (2012) 18(13):3616-27. doi:10.1158/1078-0432.CCR-11-2855
130. Mangoni M, Vozenin MC, Biti G, Deutsch E. Normal tissues toxicities triggered by combined anti-angiogenic and radiation therapies: hurdles might be ahead. Br J Cancer (2012) 107(2):308-14. doi:10.1038/bjc.2012.236
131. Jackson IL, Vujaskovic Z, Down JD. A further comparison of pathologies after thoracic irradiation among different mouse strains: finding the best preclinical model for evaluating therapies directed against radiation-induced lung damage. Radiat Res (2011) 175(4):510-8. doi:10.1667/RR2421.1
132. Walkin L, Herrick SE, Summers A, Brenchley PE, Hoff CM, Korstanje R, et al. The role of mouse strain differences in the susceptibility to fibrosis: a systematic review. Fibrogenesis Tissue Repair (2013) 6(1):18. doi:10.1186/1755-1536-6-18
133. Ao X, Zhao L, Davis MA, Lubman DM, Lawrence TS, Kong FM. Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice. J Hematol Oncol (2009) 2:6. doi:10.1186/1756-8722-2-6
134. Haston CK, Tomko TG, Godin N, Kerckhoff L, Hallett MT. Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions. J Med Genet (2005) 42(6):464-73. doi:10.1136/jmg.2004.027938
135. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol (2008) 40(3):362-82. doi:10.1016/j.biocel.2007.08.011
136. Gasse P, Mary C, Guenon I, Noulin N, Charron S, Schnyder-Candrian S, et al. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest (2007) 117(12):3786-99.
137. Brickey WJ, Neuringer IP, Walton W, Hua X, Wang EY, Jha S, et al. MyD88 provides a protective role in long-term radiation-induced lung injury. Int J Radiat Biol (2012) 88(4):335-47. doi:10.3109/09553002.2012.652723
138. Yoshii Y. Pathological review of late cerebral radionecrosis. Brain Tumor Pathol (2008) 25(2):51-8. doi:10.1007/s10014-008-0233-9
139. Moravan MJ, Olschowka JA, Williams JP, O'Banion MK. Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain. Radiat Res (2011) 176(4):459-73. doi:10.1667/RR2587.1
140. Paun A, Kunwar A, Haston CK. Acute adaptive immune response correlates with late radiation-induced pulmonary fibrosis in mice. Radiat Oncol (2015) 10:45. doi:10.1186/s13014-015-0359-y
141. Zheng X, Guo Y, Wang L, Zhang H, Wang S, Wang L, et al. Recovery profiles of T-cell subsets following low-dose total body irradiation and improvement with cinnamon. Int J Radiat Oncol Biol Phys (2015) 93(5):1118-26. doi:10.1016/j.ijrobp.2015.08.034
142. Wirsdorfer F, Cappuccini F, Niazman M, de Leve S, Westendorf AM, Ludemann L, et al. Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+ FoxP3+ regulatory T cells. Radiat Oncol (2014) 9:98. doi:10.1186/1748-717X-9-98
143. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2007) 81(1):1-5. doi:10.1189/jlb.0306164
144. Venereau E, Ceriotti C, Bianchi ME. DAMPs from cell death to new life. Front Immunol (2015) 6:422. doi:10.3389/fimmu.2015.00422
145. Matzinger P. The danger model: a renewed sense of self. Science (2002) 296(5566):301-5. doi:10.1126/science.1071059
146. Wang L, Zhang J, Wang B, Wang G, Xu J. Blocking HMGB1 signal pathway protects early radiation-induced lung injury. Int J Clin Exp Pathol (2015) 8(5):4815-22.
147. Tolle LB, Standiford TJ. Danger-associated molecular patterns (DAMPs) in acute lung injury. J Pathol (2013) 229(2):145-56. doi:10.1002/path.4124
148. Pouwels SD, Heijink IH, van Oosterhout AJ, Nawijn MC. A specific DAMP profile identifies susceptibility to smoke-induced airway inflammation. Eur Respir J (2014) 43(4):1183-6. doi:10.1183/09031936.00127813
149. Kuipers MT, van der Poll T, Schultz MJ, Wieland CW. Bench-to-bedside review: damage-associated molecular patterns in the onset of ventilator-induced lung injury. Crit Care (2011) 15(6):235. doi:10.1186/cc10437
150. Nettelbladt O, Tengblad A, Hallgren R. Lung accumulation of hyaluronan parallels pulmonary edema in experimental alveolitis. Am J Physiol (1989) 257(6 Pt 1):L379-84.
151. Nettelbladt O, Hallgren R. Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat. Am Rev Respir Dis (1989) 140(4):1028-32. doi:10.1164/ajrccm/140.4.1028
152. Ratikan JA, Micewicz ED, Xie MW, Schaue D. Radiation takes its toll. Cancer Lett (2015) 368(2):238-45. doi:10.1016/j.canlet.2015.03.031
153. Schaue D, Kachikwu EL, McBride WH. Cytokines in radiobiological responses: a review. Radiat Res (2012) 178(6):505-23. doi:10.1667/RR3031.1
154. Johnston CJ, Williams JP, Okunieff P, Finkelstein JN. Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families. Radiat Res (2002) 157(3):256-65. doi:10.1667/0033-7587(2002)157[0256:RIPFEO]2.0.CO;2
155. Hong JH, Chiang CS, Tsao CY, Lin PY, McBride WH, Wu CJ. Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation. Int J Radiat Biol (1999) 75(11):1421-7. doi:10.1080/095530099139287
156. Sohn SH, Lee JM, Park S, Yoo H, Kang JW, Shin D, et al. The inflammasome accelerates radiation-induced lung inflammation and fibrosis in mice. Environ Toxicol Pharmacol (2015) 39(2):917-26. doi:10.1016/j.etap.2015.02.019
157. Hong JH, Jung SM, Tsao TC, Wu CJ, Lee CY, Chen FH, et al. Bronchoalveolar lavage and interstitial cells have different roles in radiation-induced lung injury. Int J Radiat Biol (2003) 79(3):159-67. doi:10.1080/0955300031000076894
158. Pardo A, Smith KM, Abrams J, Coffman R, Bustos M, McClanahan TK, et al. CCL18/DC-CK-1/PARC up-regulation in hypersensitivity pneumonitis. J Leukoc Biol (2001) 70(4):610-6.
159. Prasse A, Pechkovsky DV, Toews GB, Jungraithmayr W, Kollert F, Goldmann T, et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med (2006) 173(7):781-92. doi:10.1164/rccm.200509-1518OC
160. Luzina IG, Atamas SP, Wise R, Wigley FM, Xiao HQ, White B. Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am J Respir Cell Mol Biol (2002) 26(5):549-57. doi:10.1165/ajrcmb.26.5.4683
161. Pochetuhen K, Luzina IG, Lockatell V, Choi J, Todd NW, Atamas SP. Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am J Pathol (2007) 171(2):428-37. doi:10.2353/ajpath.2007.061167
162. Inoue T, Fujishima S, Ikeda E, Yoshie O, Tsukamoto N, Aiso S, et al. CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis. Eur Respir J (2004) 24(1):49-56. doi:10.1183/09031936.04.00110203
163. Yogo Y, Fujishima S, Inoue T, Saito F, Shiomi T, Yamaguchi K, et al. Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis. Respir Res (2009) 10:80. doi:10.1186/1465-9921-10-80
164. Xu J, Mora A, Shim H, Stecenko A, Brigham KL, Rojas M. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis. Am J Respir Cell Mol Biol (2007) 37(3):291-9. doi:10.1165/rcmb.2006-0187OC
165. Choi YW, Munden RF, Erasmus JJ, Park KJ, Chung WK, Jeon SC, et al. Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis. Radiographics (2004) 24(4):985-97; discussion 98. doi:10.1148/rg.244035160
166. Gordon S. Alternative activation of macrophages. Nat Rev Immunol (2003) 3(1):23-35. doi:10.1038/nri978
167. Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM. Interferon-gamma inhibits experimental renal fibrosis. Kidney Int (1999) 56(6):2116-27. doi:10.1046/j.1523-1755.1999.00775.x
168. Pelus LM, Fukuda S. Chemokine-mobilized adult stem cells; defining a better hematopoietic graft. Leukemia (2008) 22(3):466-73. doi:10.1038/sj.leu.2405021
169. Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman J, Pecorelli S, et al. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys (2000) 48(4):997-1006. doi:10.1016/S0360-3016(00)00769-0
170. Rotstein S, Blomgren H, Petrini B, Wasserman J, Baral E. Long term effects on the immune system following local radiation therapy for breast cancer. I. Cellular composition of the peripheral blood lymphocyte population. Int J Radiat Oncol Biol Phys (1985) 11(5):921-5. doi:10.1016/0360-3016(85)90114-2
171. Newman GH, Rees GJ, Jones RS, Grove EA, Preece AW. Changes in helper and suppressor T lymphocytes following radiotherapy for breast cancer. Clin Radiol (1987) 38(2):191-3. doi:10.1016/S0009-9260(87)80032-6
172. Maity A, McKenna WG, Muschel RJ. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol (1994) 31(1):1-13. doi:10.1016/0167-8140(94)90408-1
173. Goans RE, Waselenko JK. Medical management of radiological casualties. Health Phys (2005) 89(5):505-12. doi:10.1097/01.HP.0000172144.94491.84
174. Yan L, Wu M, Ba N, Shi G, Wang L, Zhang H. Changes in T-lymphocytes in lung cancer patients after hyperthermic intraperitoneal chemotherapy or radiotherapy. Genet Mol Res (2016) 15(2). doi:10.4238/gmr.15027865
175. Cho O, Oh YT, Chun M, Noh OK, Lee HW. Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer. Tumour Biol (2016) 37(1):971-8. doi:10.1007/s13277-015-3888-y
176. Han G, Zhang H, Xie CH, Zhou YF. Th2-like immune response in radiation-induced lung fibrosis. Oncol Rep (2011) 26(2):383-8.
177. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 194(6):809-21. doi:10.1084/jem.194.6.809
178. Chen J, Wang Y, Mei Z, Zhang S, Yang J, Li X, et al. Radiation-induced lung fibrosis in a tumor-bearing mouse model is associated with enhanced type-2 immunity. J Radiat Res (2016) 57(2):133-41. doi:10.1093/jrr/rrv077
179. Karo-Atar D, Bordowitz A, Wand O, Pasmanik-Chor M, Fernandez IE, Itan M, et al. A protective role for IL-13 receptor alpha 1 in bleomycin-induced pulmonary injury and repair. Mucosal Immunol (2016) 9(1):240-53. doi:10.1038/mi.2015.56
180. Arras M, Huaux F, Vink A, Delos M, Coutelier JP, Many MC, et al. Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. Am J Respir Cell Mol Biol (2001) 24(4):368-75. doi:10.1165/ajrcmb.24.4.4249
181. Paun A, Lemay AM, Haston CK. Gene expression profiling distinguishes radiation-induced fibrosing alveolitis from alveolitis in mice. Radiat Res (2010) 173(4):512-21. doi:10.1667/RR1798.1
182. Komura K, Yanaba K, Horikawa M, Ogawa F, Fujimoto M, Tedder TF, et al. CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model. Arthritis Rheum (2008) 58(11):3574-84. doi:10.1002/art.23995
183. Arras M, Louahed J, Simoen V, Barbarin V, Misson P, van den Brule S, et al. B lymphocytes are critical for lung fibrosis control and prostaglandin E2 regulation in IL-9 transgenic mice. Am J Respir Cell Mol Biol (2006) 34(5):573-80. doi:10.1165/rcmb.2004-0383OC
184. Clark JG, Kostal KM, Marino BA. Modulation of collagen production following bleomycin-induced pulmonary fibrosis in hamsters. Presence of a factor in lung that increases fibroblast prostaglandin E2 and cAMP and suppresses fibroblast proliferation and collagen production. J Biol Chem (1982) 257(14):8098-105.
185. Xu L, Xiong S, Guo R, Yang Z, Wang Q, Xiao F, et al. Transforming growth factor beta3 attenuates the development of radiation-induced pulmonary fibrosis in mice by decreasing fibrocyte recruitment and regulating IFN-gamma/IL-4 balance. Immunol Lett (2014) 162(1 Pt A):27-33. doi:10.1016/j.imlet.2014.06.010
186. Prochazkova J, Fric J, Pokorna K, Neuwirth A, Krulova M, Zajicova A, et al. Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells. Immunology (2009) 128(1 Suppl):e670-8. doi:10.1111/j.1365-2567.2009.03060.x
187. Kumar RK, O'Grady R, Maronese SE, Wilson MR. Epithelial cell-derived transforming growth factor-beta in bleomycin-induced pulmonary injury. Int J Exp Pathol (1996) 77(3):99-107. doi:10.1046/j.1365-2613.1996.586969.x
188. Khalil N, Bereznay O, Sporn M, Greenberg AH. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med (1989) 170(3):727-37. doi:10.1084/jem.170.3.727
189. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int (1997) 51(5):1376-82. doi:10.1038/ki.1997.188
190. Martin M, Lefaix J, Delanian S. TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys (2000) 47(2):277-90. doi:10.1016/S0360-3016(00)00435-1
191. Rube CE, Uthe D, Schmid KW, Richter KD, Wessel J, Schuck A, et al. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys (2000) 47(4):1033-42. doi:10.1016/S0360-3016(00)00482-X
192. Lo Re S, Lecocq M, Uwambayinema F, Yakoub Y, Delos M, Demoulin JB, et al. Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis. Am J Respir Crit Care Med (2011) 184(11):1270-81. doi:10.1164/rccm.201103-0516OC
193. Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol (2016) 16(11):676-89. doi:10.1038/nri.2016.95
194. Siede J, Frohlich A, Datsi A, Hegazy AN, Varga DV, Holecska V, et al. IL-33 receptor-expressing regulatory T cells are highly activated, Th2 biased and suppress CD4 T cell proliferation through IL-10 and TGFbeta release. PLoS One (2016) 11(8):e0161507. doi:10.1371/journal.pone.0161507
195. Arpaia N, Green JA, Moltedo B, Arvey A, Hemmers S, Yuan S, et al. A distinct function of regulatory T cells in tissue protection. Cell (2015) 162(5):1078-89. doi:10.1016/j.cell.2015.08.021
196. Boveda-Ruiz D, D'Alessandro-Gabazza CN, Toda M, Takagi T, Naito M, Matsushima Y, et al. Differential role of regulatory T cells in early and late stages of pulmonary fibrosis. Immunobiology (2013) 218(2):245-54. doi:10.1016/j.imbio.2012.05.020
197. Kotsianidis I, Nakou E, Bouchliou I, Tzouvelekis A, Spanoudakis E, Steiropoulos P, et al. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 179(12):1121-30. doi:10.1164/rccm.200812-1936OC
198. Song L, Weng D, Liu F, Chen Y, Li C, Dong L, et al. Tregs promote the differentiation of Th17 cells in silica-induced lung fibrosis in mice. PLoS One (2012) 7(5):e37286. doi:10.1371/journal.pone.0037286
199. Trujillo G, Hartigan AJ, Hogaboam CM. T regulatory cells and attenuated bleomycin-induced fibrosis in lungs of CCR7-/-mice. Fibrogenesis Tissue Repair (2010) 3:18. doi:10.1186/1755-1536-3-18
200. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science (1995) 270(5234):286-90. doi:10.1126/science.270.5234.286
201. Wang LP, Wang YW, Wang BZ, Sun GM, Wang XY, Xu JL. Expression of interleukin-17A in lung tissues of irradiated mice and the influence of dexamethasone. ScientificWorldJournal (2014) 2014:251067. doi:10.1155/2014/251067
202. Hong JH, Chiang CS, Tsao CY, Lin PY, Wu CJ, McBride WH. Can short-term administration of dexamethasone abrogate radiation-induced acute cytokine gene response in lung and modify subsequent molecular responses? Int J Radiat Oncol Biol Phys (2001) 51(2):296-303. doi:10.1016/S0360-3016(01)01702-3
203. Hamama S, Gilbert-Sirieix M, Vozenin MC, Delanian S. Radiation-induced enteropathy: molecular basis of pentoxifylline-vitamin E anti-fibrotic effect involved TGF-beta1 cascade inhibition. Radiother Oncol (2012) 105(3):305-12. doi:10.1016/j.radonc.2012.08.023
204. Ozturk B, Egehan I, Atavci S, Kitapci M. Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial. Int J Radiat Oncol Biol Phys (2004) 58(1):213-9. doi:10.1016/S0360-3016(03)01444-5
205. Misirlioglu CH, Demirkasimoglu T, Kucukplakci B, Sanri E, Altundag K. Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer. Med Oncol (2007) 24(3):308-11. doi:10.1007/s12032-007-0006-z
206. Ward WF, Lin PJ, Wong PS, Behnia R, Jalali N. Radiation pneumonitis in rats and its modification by the angiotensin-converting enzyme inhibitor captopril evaluated by high-resolution computed tomography. Radiat Res (1993) 135(1):81-7. doi:10.2307/3578400
207. Delfraissy JF, Galanaud P, Balavoine JF, Wallon C, Dormont J. Captopril and immune regulation. Kidney Int (1984) 25(6):925-9. doi:10.1038/ki.1984.111
208. Smart YC, Gillies AH, Waga SW, Carney SL, Smith AJ, Burton RC. Effects of captopril on circulating T lymphocyte subsets. Int J Clin Pharmacol Ther Toxicol (1987) 25(7):389-91.
209. Ehlers MR, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry (1989) 28(13):5311-8. doi:10.1021/bi00439a001
210. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J (1993) 290(Pt 1):33-40. doi:10.1042/bj2900033
211. Kharofa J, Cohen EP, Tomic R, Xiang Q, Gore E. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int J Radiat Oncol Biol Phys (2012) 84(1):238-43. doi:10.1016/j.ijrobp.2011.11.013
212. Jenkins P, Watts J. An improved model for predicting radiation pneumonitis incorporating clinical and dosimetric variables. Int J Radiat Oncol Biol Phys (2011) 80(4):1023-9. doi:10.1016/j.ijrobp.2010.03.058
213. Kohl RR, Kolozsvary A, Brown SL, Zhu G, Kim JH. Differential radiation effect in tumor and normal tissue after treatment with ramipril, an angiotensin-converting enzyme inhibitor. Radiat Res (2007) 168(4):440-5. doi:10.1667/RR0707.1
214. Wang H, Liao Z, Zhuang Y, Xu T, Nguyen QN, Levy LB, et al. Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database. Int J Radiat Oncol Biol Phys (2013) 87(5):1071-7. doi:10.1016/j.ijrobp.2013.08.033
215. Small W Jr, James JL, Moore TD, Fintel DJ, Lutz ST, Movsas B, et al. Utility of the ACE inhibitor captopril in mitigating radiation-associated pulmonary toxicity in lung cancer: results from NRG oncology RTOG 0123. Am J Clin Oncol (2016). doi:10.1097/COC.0000000000000289
216. Randak C, Brabletz T, Hergenrother M, Sobotta I, Serfling E. Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. EMBO J (1990) 9(8):2529-36.
217. Moolman JA, Bardin PG, Rossouw DJ, Joubert JR. Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. Thorax (1991) 46(8):592-5. doi:10.1136/thx.46.8.592
218. Muraoka T, Bandoh S, Fujita J, Horiike A, Ishii T, Tojo Y, et al. Corticosteroid refractory radiation pneumonitis that remarkably responded to cyclosporin A. Intern Med (2002) 41(9):730-3. doi:10.2169/internalmedicine.41.730
219. Abdou NI, Zweiman B, Casella SR. Effects of azathioprine therapy on bone marrow-dependent and thymus-dependent cells in man. Clin Exp Immunol (1973) 13(1):55-64.
220. Dimitriu A, Fauci AS. Activation of human B lymphocytes. XI. Differential effects of azathioprine on B lymphocytes and lymphocyte subpopulations regulating B cell function. J Immunol (1978) 121(6):2335-9.
221. McCarty MJ, Lillis P, Vukelja SJ. Azathioprine as a steroid-sparing agent in radiation pneumonitis. Chest (1996) 109(5):1397-400. doi:10.1378/chest.109.5.1397
222. Kwok E, Chan CK. Corticosteroids and azathioprine do not prevent radiation-induced lung injury. Can Respir J (1998) 5(3):211-4. doi:10.1155/1998/896131
223. Giridhar P, Mallick S, Rath GK, Julka PK. Radiation induced lung injury: prediction, assessment and management. Asian Pac J Cancer Prev (2015) 16(7):2613-7. doi:10.7314/APJCP.2015.16.7.2613
224. Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol (2012) 51(8):975-83. doi:10.3109/0284186X.2012.718093
225. Takeda A, Kunieda E, Ohashi T, Aoki Y, Oku Y, Enomoto T, et al. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy. Chest (2012) 141(4):858-66. doi:10.1378/chest.11-1193
226. Zhang XJ, Sun JG, Sun J, Ming H, Wang XX, Wu L, et al. Prediction of radiation pneumonitis in lung cancer patients: a systematic review. J Cancer Res Clin Oncol (2012) 138(12):2103-16. doi:10.1007/s00432-012-1284-1
227. Chen Y, Hyrien O, Williams J, Okunieff P, Smudzin T, Rubin P. Interleukin (IL)-1A and IL-6: applications to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys (2005) 62(1):260-6. doi:10.1016/j.ijrobp.2005.01.041
228. Herskind C, Talbot CJ, Kerns SL, Veldwijk MR, Rosenstein BS, West CM. Radiogenomics: a systems biology approach to understanding genetic risk factors for radiotherapy toxicity? Cancer Lett (2016) 382(1):95-109. doi:10.1016/j.canlet.2016.02.035
229. Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med (2013) 5(167):167sr1. doi:10.1126/scitranslmed.3004700
230. Straub JM, New J, Hamilton CD, Lominska C, Shnayder Y, Thomas SM. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol (2015) 141(11):1985-94. doi:10.1007/s00432-015-1974-6
231. Williams JP, Johnston CJ, Finkelstein JN. Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction? Curr Drug Targets (2010) 11(11):1386-94. doi:10.2174/1389450111009011386
232. Anscher MS. Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist (2010) 15(4):350-9. doi:10.1634/theoncologist.2009-S101
233. Wang BZ, Wang LP, Han H, Cao FL, Li GY, Xu JL, et al. Interleukin-17A antagonist attenuates radiation-induced lung injuries in mice. Exp Lung Res (2014) 40(2):77-85. doi:10.3109/01902148.2013.872210
234. Togo S, Liu X, Wang X, Sugiura H, Kamio K, Kawasaki S, et al. PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-(beta)1-stimulated fibroblasts. Am J Physiol Lung Cell Mol Physiol (2009) 296(6):L959-69. doi:10.1152/ajplung.00508.2007
235. Herbert C, Hettiaratchi A, Webb DC, Thomas PS, Foster PS, Kumar RK. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma. Clin Exp Allergy (2008) 38(5):847-56. doi:10.1111/j.1365-2222.2008.02950.x
236. Wan YY, Flavell RA. TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol (2008) 28(6):647-59. doi:10.1007/s10875-008-9251-y
237. Tran DQ. TGF-beta: the sword, the wand, and the shield of FOXP3(+) regulatory T cells. J Mol Cell Biol (2012) 4(1):29-37. doi:10.1093/jmcb/mjr033
238. Varga J, Whitfield ML. Transforming growth factor-beta in systemic sclerosis (scleroderma). Front Biosci (Schol Ed) (2009) 1:226-35. doi:10.2741/s22
239. Meng XM, Chung AC, Lan HY. Role of the TGF-beta/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond) (2013) 124(4):243-54. doi:10.1042/CS20120252
240. Dooley S, ten Dijke P. TGF-beta in progression of liver disease. Cell Tissue Res (2012) 347(1):245-56. doi:10.1007/s00441-011-1246-y
241. Smilowitz HM, Sasso D, Lee EW, Goh G, Micca PL, Dilmanian FA. Therapy model for advanced intracerebral B16 mouse melanoma using radiation therapy combined with immunotherapy. Cancer Immunol Immunother (2013) 62(7):1187-97. doi:10.1007/s00262-013-1423-9
242. Byrne WL, Mills KH, Lederer JA, O'Sullivan GC. Targeting regulatory T cells in cancer. Cancer Res (2011) 71(22):6915-20. doi:10.1158/0008-5472.CAN-11-1156
243. Fernandez P, Perez-Aso M, Smith G, Wilder T, Trzaska S, Chiriboga L, et al. Extracellular generation of adenosine by the ectonucleotidases CD39 and CD73 promotes dermal fibrosis. Am J Pathol (2013) 183(6):1740-6. doi:10.1016/j.ajpath.2013.08.024
244. Peng Z, Fernandez P, Wilder T, Yee H, Chiriboga L, Chan ES, et al. Ecto-5'-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. Nucleosides Nucleotides Nucleic Acids (2008) 27(6):821-4. doi:10.1080/15257770802146403
245. Zhou Y, Schneider DJ, Morschl E, Song L, Pedroza M, Karmouty-Quintana H, et al. Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury. J Immunol (2011) 186(2):1097-106. doi:10.4049/jimmunol.1002907
246. Cekic C, Linden J. Purinergic regulation of the immune system. Nat Rev Immunol (2016) 16(3):177-92. doi:10.1038/nri.2016.4
247. Allard D, Allard B, Gaudreau PO, Chrobak P, Stagg J. CD73-adenosine: a next-generation target in immuno-oncology. Immunotherapy (2016) 8(2):145-63. doi:10.2217/imt.15.106
248. Nicolay NH, Lopez Perez R, Debus J, Huber PE. Mesenchymal stem cells-a new hope for radiotherapy-induced tissue damage? Cancer Lett (2015) 366(2):133-40. doi:10.1016/j.canlet.2015.06.012
249. Martire A, Bedada FB, Uchida S, Poling J, Kruger M, Warnecke H, et al. Mesenchymal stem cells attenuate inflammatory processes in the heart and lung via inhibition of TNF signaling. Basic Res Cardiol (2016) 111(5):54. doi:10.1007/s00395-016-0573-2
250. Dong LH, Jiang YY, Liu YJ, Cui S, Xia CC, Qu C, et al. The anti-fibrotic effects of mesenchymal stem cells on irradiated lungs via stimulating endogenous secretion of HGF and PGE2. Sci Rep (2015) 5:8713. doi:10.1038/srep08713
251. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A (2007) 104(26):11002-7. doi:10.1073/pnas.0704421104
252. Lan YW, Choo KB, Chen CM, Hung TH, Chen YB, Hsieh CH, et al. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis. Stem Cell Res Ther (2015) 6:97. doi:10.1186/s13287-015-0081-6
253. Jones S, Horwood N, Cope A, Dazzi F. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol (2007) 179(5):2824-31. doi:10.4049/jimmunol.179.5.2824
254. Glenn JD, Whartenby KA. Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy. World J Stem Cells (2014) 6(5):526-39. doi:10.4252/wjsc.v6.i5.526
255. Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther (2016) 7(1):125. doi:10.1186/s13287-016-0363-7
256. Alkhouri H, Poppinga WJ, Tania NP, Ammit A, Schuliga M. Regulation of pulmonary inflammation by mesenchymal cells. Pulm Pharmacol Ther (2014) 29(2):156-65. doi:10.1016/j.pupt.2014.03.001
257. Jun D, Garat C, West J, Thorn N, Chow K, Cleaver T, et al. The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells (2011) 29(4):725-35. doi:10.1002/stem.604
258. Chow K, Fessel JP, Kaoriihida S, Schmidt EP, Gaskill C, Alvarez D, et al. Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling. Pulm Circ (2013) 3(1):31-49. doi:10.4103/2045-8932.109912
259. Marriott S, Baskir RS, Gaskill C, Menon S, Carrier EJ, Williams J, et al. ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling. Am J Physiol Cell Physiol (2014) 307(8):C684-98. doi:10.1152/ajpcell.00114.2014
260. Luo Y, Xu W, Chen H, Warburton D, Dong R, Qian B, et al. A novel profibrotic mechanism mediated by TGFbeta-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells. J Pathol (2015) 236(3):384-94. doi:10.1002/path.4530
261. Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA, et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell (2015) 16(1):51-66. doi:10.1016/j.stem.2014.11.004
262. Xie T, Liang J, Liu N, Huan C, Zhang Y, Liu W, et al. Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis. J Clin Invest (2016) 126(8):3063-79. doi:10.1172/JCI85328
263. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A (2003) 100(14):8407-11. doi:10.1073/pnas.1432929100
264. Duffy MM, Ritter T, Ceredig R, Griffin MD. Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther (2011) 2(4):34. doi:10.1186/scrt75
265. Swaney JS, Chapman C, Correa LD, Stebbins KJ, Bundey RA, Prodanovich PC, et al. A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. Br J Pharmacol (2010) 160(7):1699-713. doi:10.1111/j.1476-5381.2010.00828.x
266. Park Y, Oh SJ, Chung DH. CD4(+)CD25(+) regulatory T cells attenuate hypersensitivity pneumonitis by suppressing IFN-gamma production by CD4(+) and CD8(+) T cells. J Leukoc Biol (2009) 86(6):1427-37. doi:10.1189/jlb.0908542